Benzimidazoles
Concept
Vocabulary Service
Overview
subject area of
-
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
-
A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery Academic Article
-
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN) Academic Article
-
A logical approach to surgical thromboprophylaxis Academic Article
-
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191 Academic Article
-
A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200 Academic Article
-
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group Academic Article
-
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study Academic Article
-
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials Academic Article
-
Acid suppression in healthy subjects following lansoprazole or pantoprazole Academic Article
-
Activated prothrombin complex concentrate for dabigatran-associated bleeding Academic Article
-
Acute Precipitants of Congestive Heart Failure Exacerbations Academic Article
-
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes Academic Article
-
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
-
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk Academic Article
-
Additional Events in the RE-LY Trial Academic Article
-
Adherence to anticoagulant treatment with dabigatran in a real‐world setting Academic Article
-
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial Academic Article
-
Advances in treatment and management Academic Article
-
Advantages and limitations of the new anticoagulants Academic Article
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction Academic Article
-
Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures Academic Article
-
Albuminuria in chronic heart failure: prevalence and prognostic importance Academic Article
-
Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) Academic Article
-
Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial Academic Article
-
Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors? Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Antithrombotic Therapy for Atrial Fibrillation Academic Article
-
Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Academic Article
-
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
-
Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study). Academic Article
-
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke Academic Article
-
Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study Academic Article
-
Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure Academic Article
-
Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction Academic Article
-
Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation Academic Article
-
Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme Academic Article
-
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) Academic Article
-
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies Academic Article
-
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease Academic Article
-
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease Academic Article
-
Body Mass Index and Prognosis in Patients With Chronic Heart Failure Academic Article
-
Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Academic Article
-
Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough Academic Article
-
Candesartan for the management of heart failure: more than an alternative Academic Article
-
Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design Academic Article
-
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk Academic Article
-
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation Academic Article
-
Changes in Renal Function in Patients With Atrial Fibrillation Academic Article
-
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM Academic Article
-
Clinical Characteristics and Outcomes of Young and Very Young Adults With Heart Failure Academic Article
-
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure Academic Article
-
Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program Academic Article
-
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial Academic Article
-
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme Academic Article
-
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
-
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development Academic Article
-
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? Academic Article
-
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure Academic Article
-
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure Academic Article
-
Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis Academic Article
-
Compound- and fiber type-selective requirement of AMPKγ3 for insulin-independent glucose uptake in skeletal muscle Academic Article
-
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial Academic Article
-
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure Academic Article
-
Control of vascular changes by renin–angiotensin–aldosterone system in salt-sensitive hypertension Academic Article
-
Controlling Gene Expression in Living Cells Through Small Molecule-RNA Interactions Academic Article
-
Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist Academic Article
-
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Academic Article
-
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective Academic Article
-
Dabigatran Etexilate Academic Article
-
Dabigatran Etexilate: Future Directions in Anticoagulant Treatment Academic Article
-
Dabigatran Versus Warfarin Academic Article
-
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation Academic Article
-
Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation Academic Article
-
Dabigatran and risk of myocardial infarction Academic Article
-
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management Academic Article
-
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Academic Article
-
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial Academic Article
-
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial Academic Article
-
Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation Academic Article
-
Dabigatran etexilate for prevention of venous thromboembolism Academic Article
-
Dabigatran for patients with a mechanical valve Academic Article
-
Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial Academic Article
-
Dabigatran in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran monitoring made simple? Academic Article
-
Dabigatran versus Warfarin for Venous Thromboembolism Academic Article
-
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Academic Article
-
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Academic Article
-
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
-
Dabigatran versus warfarin in patients with mechanical heart valves: reply Academic Article
-
Dabigatran-Induced Acute Hepatitis Academic Article
-
Dabigatran-related coagulopathy: when can we assume the effect has “worn off”? Academic Article
-
Dabigatran: ready for prime time? Academic Article
-
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Academic Article
-
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction Academic Article
-
Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus Academic Article
-
Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Academic Article
-
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies Academic Article
-
Early Relief of Upper Gastrointestinal Dyspeptic Symptoms: A Survey of Empirical Therapy with Pantoprazole in Canadian Clinical Practice Academic Article
-
Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients Academic Article
-
Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke Academic Article
-
Effect of Telmisartan on Renal Outcomes Academic Article
-
Effect of candesartan on New York Heart Association functional classResults of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure Academic Article
-
Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial Academic Article
-
Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes Academic Article
-
Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease Academic Article
-
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study Academic Article
-
Effects of blood pressure and lipid lowering on cognition Academic Article
-
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Academic Article
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Academic Article
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Academic Article
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Academic Article
-
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker Academic Article
-
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease Academic Article
-
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals Academic Article
-
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial Academic Article
-
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation Academic Article
-
Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Academic Article
-
Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial - Academic Article
-
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Academic Article
-
Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy Academic Article
-
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa Academic Article
-
Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis Academic Article
-
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
-
Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both Academic Article
-
Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1 Academic Article
-
Evolving use of new oral anticoagulants for treatment of venous thromboembolism Academic Article
-
Experimental modification of PC12 neurite shape with the microtubule-depolymerizing drug Nocodazole: a serial electron microscopic study of neurite shape control. Academic Article
-
Extended Anticoagulation in Venous Thromboembolism Academic Article
-
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Academic Article
-
Extended anticoagulation in venous thromboembolism. Academic Article
-
Extended anticoagulation in venous thromboembolism. Academic Article
-
Extended anticoagulation in venous thromboembolism. Academic Article
-
Factor Xa and thrombin as targets for new oral anticoagulants Academic Article
-
From the hope to the ontarget and the transcend studies: challenges in improving prognosis Academic Article
-
Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies Academic Article
-
Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding Academic Article
-
Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema Academic Article
-
Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk Academic Article
-
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme Academic Article
-
Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression. Academic Article
-
Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum Academic Article
-
Home-monitoring of oral anticoagulation vs. dabigatran Academic Article
-
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
-
Idarucizumab for Dabigatran Reversal Academic Article
-
Identification of 2-benzimidazolyl urea as a new antimitotic compound based on cross resistance studies with nocodazole resistant mutants of cho cells Academic Article
-
Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure Academic Article
-
Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk Academic Article
-
Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study Academic Article
-
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure Academic Article
-
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk Academic Article
-
In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events Academic Article
-
In vitro ultraviolet-induced damage in human corneal, lens, and retinal pigment epithelial cells. Academic Article
-
Incidence and Predictors of Hyperkalemia in Patients With Heart Failure Academic Article
-
Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada Academic Article
-
Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients Academic Article
-
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure Academic Article
-
Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction Academic Article
-
Initial data supporting the design of the Candesartan in Heart failure — Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Intensity and Quality of Warfarin Anticoagulation in Chinese Patients Academic Article
-
International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction Academic Article
-
Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran Academic Article
-
Intravenous proton pump inhibitor therapy: a rationale for use. Academic Article
-
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial Academic Article
-
Is therapy of people with chronic kidney disease ONTARGET? Academic Article
-
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials Academic Article
-
Is there really misuse and abuse of dabigatran? Academic Article
-
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Academic Article
-
Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline Academic Article
-
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study Academic Article
-
Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]) Academic Article
-
Letter by Van de Werf et al Regarding Article, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians” Academic Article
-
Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke Academic Article
-
Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial Academic Article
-
Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells Academic Article
-
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin Academic Article
-
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor Academic Article
-
Management of Anticoagulation Around Pacemaker and Defibrillator Surgery Academic Article
-
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
-
Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: The role of adipocyte-derived angiotensin II Academic Article
-
Metabolic effects of telmisartan in subjects with abdominal obesity: A prospective randomized controlled trial Academic Article
-
More on Acutely Injured Patients Receiving Dabigatran Academic Article
-
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction Academic Article
-
Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine Academic Article
-
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction Academic Article
-
Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Academic Article
-
New Anticoagulants for Atrial Fibrillation Academic Article
-
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
New Anticoagulants for the Prevention of Thromboembolism Academic Article
-
New anticoagulants Conference Paper
-
New anticoagulants in atrial fibrillation management Conference Paper
-
New aspects on treatment modalities for thromboembolic episodes Academic Article
-
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
-
New oral anticoagulants and oculoplastic surgery Academic Article
-
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Academic Article
-
New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty Academic Article
-
New oral anticoagulants in elderly patients Academic Article
-
New oral anticoagulants: not quite there yet Academic Article
-
New oral anticoagulants: which one should my patient use? Academic Article
-
Newly Identified Events in the RE-LY Trial Academic Article
-
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics Academic Article
-
Novel Oral Anticoagulants: A Focused Review for Stroke Physicians Academic Article
-
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Academic Article
-
Novel oral anticoagulants in gastroenterology practice Academic Article
-
Novel oral anticoagulants in secondary prevention of stroke Academic Article
-
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits Academic Article
-
Oral Anticoagulant Therapy Academic Article
-
Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects Academic Article
-
Overview of the New Oral Anticoagulants Academic Article
-
Pantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn Academic Article
-
Patient outcomes using the European label for dabigatran Academic Article
-
Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Percutaneous needle aspiration, injection, and re-aspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts Academic Article
-
Perioperative Management of Dabigatran Academic Article
-
Perioperative management of patients who are receiving a novel oral anticoagulant Academic Article
-
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Academic Article
-
Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran Academic Article
-
Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management Academic Article
-
Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours Academic Article
-
Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues. Academic Article
-
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial Academic Article
-
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation Academic Article
-
Potential of new anticoagulants in patients with cancer Academic Article
-
Practical aspects of new oral anticoagulant use in atrial fibrillation Academic Article
-
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
-
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice Academic Article
-
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation Academic Article
-
Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme Academic Article
-
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme Academic Article
-
Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
-
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Academic Article
-
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Academic Article
-
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Academic Article
-
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program Academic Article
-
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study Academic Article
-
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate Academic Article
-
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors Academic Article
-
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran Academic Article
-
Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS) Academic Article
-
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials Academic Article
-
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding Academic Article
-
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure Academic Article
-
Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention Academic Article
-
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial Academic Article
-
Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure Academic Article
-
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure Academic Article
-
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Academic Article
-
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies Academic Article
-
Reply: regarding the effect of dabigatran plasma concentrations. Academic Article
-
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study” Academic Article
-
Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis” Academic Article
-
Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin” Academic Article
-
Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial” Academic Article
-
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Academic Article
-
Response. Academic Article
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
-
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Academic Article
-
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial Academic Article
-
Rivaroxaban for the prevention and treatment of venous thromboembolism Academic Article
-
SELIMETRY—a multicentre I-131 dosimetry trial: a clinical perspective Academic Article
-
Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis Academic Article
-
Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes Academic Article
-
Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review Academic Article
-
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219 Academic Article
-
Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure Academic Article
-
Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) Academic Article
-
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease Academic Article
-
Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation Academic Article
-
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy Academic Article
-
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Academic Article
-
Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk Academic Article
-
Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease Academic Article
-
THE DRUG TREATMENT OF DUODENAL ULCER: PHYSIOLOGICAL CONSIDERATIONS IN THE CHOICE OF THERAPY Academic Article
-
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events Academic Article
-
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events Academic Article
-
Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data. Academic Article
-
The CHARM program: the effects of candesartan for the management of patients with chronic heart failure Academic Article
-
The CHARM programme Academic Article
-
The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis Academic Article
-
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Academic Article
-
The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War? Academic Article
-
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Academic Article
-
The Mini-Mental State Examination, Clinical Factors, and Motor Vehicle Crash Risk Academic Article
-
The Oral Thrombin Inhibitor Dabigatran: Strengths and Weaknesses Academic Article
-
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics Academic Article
-
The cost implication of primary prevention in the HOPE 3 trial Academic Article
-
The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study Academic Article
-
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial Academic Article
-
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect Academic Article
-
The top 4 advances in antithrombotic care in the last year Academic Article
-
Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding Academic Article
-
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
-
Treatment of venous thromboembolism with dabigatran Academic Article
-
Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both Academic Article
-
Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation. Academic Article
-
Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease Academic Article
-
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study Academic Article
-
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
-
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin Academic Article
-
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Academic Article
-
Well-managed warfarin is superior to NOACs Response Academic Article
-
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme Academic Article
-
γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo Academic Article